C/Can 2025

City Cancer Challenge 2025 was established in 2017 by the Union for International Cancer Control.

It is a multi-sectoral initiative engaging stakeholders in the design, planning, and implementation of cancer care solutions.

The initiative’s mission is to build a collective movement of cities supported by a network of global and local partners to deliver quality, equitable and sustainable cancer treatment solutions for all.

Cancers addressed:

• Childhood

• Breast

• Cervical

• Leukemia

• Hematological

• Colorectal

• Liver

• General

Global partners:

• Access Accelerated

• AdvaMed

• American Society of Clinical Oncology

• American Society of Clinical Pathology 

• Amgen

• Bristol-Myers Squibb

• Chugai

• Dalberg

• Direct Relief

• European Society for Radiotherapy and Oncology (ESTRO)

• Icon Group

• International Atomic Energy Agency (IAEA)

• MSD

​​

• National Cancer Institute (US)
• Novartis
• Roche
• Sanofi

• ​Sanofi Espoir Foundation

• Takeda

• University of Pittsburgh Medical Center

• University de Valle

• World Bank

• World Child Cancer

• World Economic Forum

• World Health Organization/Pan
  American Health Organization